Palifermin
- Level
- Commodity
- Parent
- 51112100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112102This classification denotes a therapeutic fibroblast growth factor with the molecular formula C729H1156N204O207S10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QMS40680K6, more generally known as palifermin. European Medicines Agency schedules palifermin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21058. The term PALIFERMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3, 2002, list 48. Most nations schedule Palifermin under HS 29332990 and SITC 51573. SMILES:. As of Q4 2014, PALIFERMIN remains the US FDA Preferred Term for this commodity. . Palifermin bears US NLM identifiers UMLS ID C0677829 and NCI Concept Code C2455.
Same parent
Under 51112100 · 4Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.